An Open Label Study to Describe the Pharmacokinetics of Daptomycin in Infants
NCT00942149
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Sepsis
Interventions
DRUG:
Daptomycin
Sponsor
Duke University